All previous studies in this field were performed using various human glioblastomas lines and models, without considering the genetic makeup of the tumours (such as IDH1 mutations) making it difficult to determine whether each identified target was a pan-TAM target or was specific for a specific model. This evidence concerns the gene IDH1 and glioblastoma.